Management of acute bronchitis in healthy adults

Infectious Disease Clinics of North America

Volumn 18, Issue 4, 2004, Pages 919-937

  Aagaard, Eva ^a   Gonzales, Ralph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIBIOTIC AGENT; ANTITUSSIVE AGENT; ASCORBIC ACID; AZITHROMYCIN; C REACTIVE PROTEIN; CODEINE; CORTICOSTEROID; DEXTROMETHORPHAN; ECHINACEA EXTRACT; GLUCONATE ZINC; INFLUENZA VACCINE; MACROLIDE; OSELTAMIVIR; PELARGONIUM SIDOIDES EXTRACT; PERTUSSIS VACCINE; PLANT EXTRACT; PROCALCITONIN; RIBAVIRIN; RIMANTADINE; SIALIDASE INHIBITOR; UMCKA; UNCLASSIFIED DRUG; ZANAMIVIR; ZINC ACETATE;

ANTIBIOTIC RESISTANCE; ASTHMA; BACTERIAL INFECTION; BLOOD ANALYSIS; BRONCHITIS; BRONCHODILATING ACTIVITY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; COUGHING; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HUMAN; IMMUNE DEFICIENCY; IMMUNIZATION; IMMUNOMODULATION; MEDICAL EDUCATION; MICROBIOLOGY; MORBIDITY; MORTALITY; PATHOGENESIS; PATIENT SATISFACTION; PNEUMONIA; PREVALENCE; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; VACCINATION; VIRUS INFECTION;

ACUTE DISEASE; ADULT; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; BACTERIAL INFECTIONS; BRONCHITIS; BRONCHODILATOR AGENTS; DRUG UTILIZATION; HUMANS; IMMUNOLOGIC FACTORS; INFLUENZA, HUMAN; PNEUMONIA;

EID: 8844280942     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2004.07.001     Document Type: Review

References (173)

1. V. Benson, and M.A. Marano Current estimates from the National Health Interview Survey, 1995 Vital Health Stat 10 199 1998 1 428
2. D.K. Cherry, C.W. Burt, and D.A. Woodwell National Ambulatory Medical Care Survey: 2001 summary Adv Data 337 2003 1 44
3. D.K. Cherry, and D.A. Woodwell National Ambulatory Medical Care Survey: 2000 summary Adv Data 328 2002 1 32
4. S.M. Schappert National Ambulatory Medical Care Survey: 1989 summary Vital Health Stat 13 1992 1 80
5. S.M. Schappert National Ambulatory Medical Care Survey: 1990 summary Adv Data 1992 1 11
6. S.M. Schappert National Ambulatory Medical Care Survey: 1991 summary Adv Data 1993 1 16
7. S.M. Schappert National Ambulatory Medical Care Survey: 1992 summary Adv Data 1994 1 20
8. S.M. Schappert National Ambulatory Medical Care Survey:1994 summary Adv Data 1996 1 18
9. D.A. Woodwell National Ambulatory Medical Care Survey: 1995 summary Adv Data 1997 1 25
10. D.A. Woodwell National Ambulatory Medical Care Survey: 1996 summary Adv Data 1997 1 25
11. D.A. Woodwell National Ambulatory Medical Care Survey: 1997 summary Adv Data 1999 1 28
12. D.A. Woodwell, and S.M. Schappert National Ambulatory Medical Care Survey: 1993 summary Adv Data 1995 1 20
13. R. Kawamoto, Y. Asai, and N. Nago A study of clinical features and treatment of acute bronchitis by Japanese primary care physicians Fam Pract 15 1998 244 251
14. S. Leiner Acute bronchitis in adults: commonly diagnosed but poorly defined Nurse Pract 22 1997 104 107-8,113-7
15. K.C. Oeffinger, L.M. Snell, and B.M. Foster Diagnosis of acute bronchitis in adults: a national survey of family physicians J Fam Pract 45 1997 402 409
16. N. Stocks, and T. Fahey Labeling of acute respiratory illness: evidence of between-practitioner variation in the UK Fam Pract 19 2002 375 377
17. R.S. Irwin, L.P. Boulet, and M.M. Cloutier Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians Chest 114 1998 133S 181S
18. R.S. Irwin, and J.M. Madison The diagnosis and treatment of cough N Engl J Med 343 2000 1715 1721
19. T. Heikkinen, and A. Jarvinen The common cold Lancet 361 2003 51 59
20. T. Puhakka, M.J. Makela, and K. Malmstrom The common cold: effects of intranasal fluticasone propionate treatment J Allergy Clin Immunol 101 1998 726 731
21. D.L. Hahn, R.W. Dodge, and R. Golubjatnikov Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma JAMA 266 1991 225 230
22. W.J. Hall, and R.G. Douglas Jr. Pulmonary function during and after common respiratory infections Annu Rev Med 31 1980 233 238
23. W.J. Hall, and C.B. Hall Clinical significance of pulmonary function tests. Alterations in pulmonary function following respiratory viral infection Chest 76 1979 458 465
24. W.J. Hall, C.B. Hall, and D.M. Speers Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies Ann Intern Med 88 1978 203 205
25. J.W. Little, W.J. Hall, and R.G. Douglas Jr. Airway hyperreactivity and peripheral airway dysfunction in influenza A infection Am Rev Respir Dis 118 1978 295 303
26. A.J. Polito, and D. Proud Epithelia cells as regulators of airway inflammation J Allergy Clin Immunol 102 1998 714 718
27. D.A. Boldy, S.J. Skidmore, and J.G. Ayres Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine Respir Med 84 1990 377 385
28. H.A. Williamson Jr. Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction J Fam Pract 25 1987 251 256
29. H. Melbye, J. Kongerud, and L. Vorland Reversible airflow limitation in adults with respiratory infection Eur Respir J 7 1994 1239 1245
30. J.S. Hallett, and R.L. Jacobs Recurrent acute bronchitis: the association with undiagnosed bronchial asthma Ann Allergy 55 1985 568 570
31. H.A. Williamson Jr., and P. Schultz An association between acute bronchitis and asthma J Fam Pract 24 1987 35 38
32. R. Gonzales, J.G. Bartlett, and R.E. Besser Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background Ann Emerg Med 37 2001 720 727
33. J. Macfarlane, W. Holmes, and P. Gard Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community Thorax 56 2001 109 114
34. J.S. Jonsson, J.A. Sigurdsson, and K.G. Kristinsson Acute bronchitis in adults. How close do we come to its aetiology in general practice? Scand J Prim Health Care 15 1997 156 160
35. A.R. Falsey, and E.E. Walsh Respiratory syncytial virus infection in adults Clin Microbiol Rev 13 2000 371 384
36. J. Treanor, and A. Falsey Respiratory viral infections in the elderly Antiviral Res 44 1999 79 102
37. S.B. Greenberg Respiratory viral infections in adults Curr Opin Pulm Med 8 2002 201 208
38. M.C. Zambon, J.D. Stockton, and J.P. Clewley Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study Lancet 358 2001 1410 1416
39. G. Agius, G. Dindinaud, and R.J. Biggar An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings J Med Virol 30 1990 117 127
40. B.G. van den Hoogen, J.C. de Jong, and J. Groen A newly discovered human pneumovirus isolated from young children with respiratory tract disease Nat Med 7 2001 719 724
41. M.D. Nissen, D.J. Siebert, and I.M. Mackay Evidence of human metapneumovirus in Australian children Med J Aust 176 2002 188
42. G. Pelletier, P. Dery, and Y. Abed Respiratory tract reinfections by the new human Metapneumovirus in an immunocompromised child Emerg Infect Dis 8 2002 976 978
43. T.C. Peret, G. Boivin, and Y. Li Characterization of human metapneumoviruses isolated from patients in North America J Infect Dis 185 2002 1660 1663
44. J. Stockton, I. Stephenson, and D. Fleming Human metapneumovirus as a cause of community-acquired respiratory illness Emerg Infect Dis 8 2002 897 901
45. B.G. van den Hoogen, G.J. van Doornum, and J.C. Fockens Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients J Infect Dis 188 2003 1571 1577
46. G. Boivin, Y. Abed, and G. Pelletier Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups J Infect Dis 186 2002 1330 1334
47. B.G. van den Hoogen, D.M. Osterhaus, and R.A. Fouchier Clinical impact and diagnosis of human metapneumovirus infection Pediatr Infect Dis J 23 2004 S25 S32
48. A.R. Falsey, D. Erdman, and L.J. Anderson Human metapneumovirus infections in young and elderly adults J Infect Dis 187 2003 785 790
49. C.H. Ramirez-Ronda, Z. Fuxench-Lopez, and M. Nevarez Increased pharyngeal bacterial colonization during viral illness Arch Intern Med 141 1981 1599 1603
50. F.S. Brimblecombe, R. Cruickshank, and P.L. Masters Family studies of respiratory infections Br Med J 29 1958 119 128
51. G.H. Cassell, and B.C. Cole Mycoplasmas as agents of human disease N Engl J Med 304 1981 80 89
52. J.T. Grayston, C.C. Kuo, and S.P. Wang A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections N Engl J Med 315 1986 161 168
53. F. Blasi, S. Centanni, and L. Allegra Chlamydia pneumoniae: crossing the barriers? Eur Respir J 23 2004 499 500
54. G. Falck, L. Heyman, and J. Gnarpe Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis Scand J Infect Dis 26 1994 179 187
55. J.T. Grayston, M.B. Aldous, and A. Easton Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis J Infect Dis 168 1993 1231 1235
56. C. Jantos, P. Artelt, and H.G. Schiefer Acute lower respiratory tract infection associated with Chlamydia pneumoniae in Germany Eur J Clin Microbiol Infect Dis 12 1993 33 35
57. D. Lieberman, P. Shvartzman, and D. Lieberman Etiology of respiratory tract infection in adults in a general practice setting Eur J Clin Microbiol Infect Dis 17 1998 685 689
58. C.H. Mordhorst, S.P. Wang, and J.T. Grayston Outbreak of Chlamydia pneumoniae infection in four farm families Eur J Clin Microbiol Infect Dis 11 1992 617 620
59. G.A. Tannock, A.L. Reid, and S.M. Gillett A study of respiratory infections in a healthy adult population during the 1987 Australian winter Fam Pract 10 1993 378 386
60. D.H. Thom, J.T. Grayston, and L.A. Campbell Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients Eur J Clin Microbiol Infect Dis 13 1994 785 792
61. S.W. Wright, K.M. Edwards, and M.D. Decker Prevalence of positive serology for acute Chlamydia pneumoniae infection in emergency department patients with persistent cough Acad Emerg Med 4 1997 179 183
62. T.M. File Jr., J. Segreti, and L. Dunbar A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia Antimicrob Agents Chemother 41 1997 1965 1972
63. M.T. Kauppinen, P. Saikku, and P. Kujala Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia Thorax 51 1996 185 189
64. D.E. King, W.C. Williams, and L. Bishop Effectiveness of erythromycin in the treatment of acute bronchitis J Fam Pract 42 1996 601 605
65. J. Macfarlane, J. Prewett, and D. Rose Prospective case-control study of role of infection in patients who reconsult after initial antibiotic treatment for lower respiratory tract infection in primary care Br Med J 315 1997 1206 1210
66. E. Grimprel, P. Begue, and I. Anjak Long-term human serum antibody responses after immunization with whole-cell pertussis vaccine in France Clin Diagn Lab Immunol 3 1996 93 97
67. Q. He, M.K. Viljanen, and S. Nikkari Outcomes of Bordetella pertussis infection in different age groups of an immunized population J Infect Dis 170 1994 873 877
68. D. Jenkinson Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study BMJ (Clin.Res Ed) 296 1988 612 614
69. S. Lugauer, U. Heininger, and J.D. Cherry Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine Eur J Pediatr 161 2002 142 146
70. S. Salmaso, P. Mastrantonio, and A.E. Tozzi Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience Pediatrics 108 2001 E81
71. C.H. Wirsing von Konig, S. Postels-Multani, and H.L. Bock Pertussis in adults: frequency of transmission after household exposure Lancet 346 1995 1326 1329
72. S. Gilberg, E. Njamkepo, and C. Du Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage J Infect Dis 186 2002 415 418
73. D. Guris, P.M. Strebel, and B. Bardenheier Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996 Clin Infect Dis 28 1999 1230 1237
74. E. Miller, D.M. Fleming, and L.A. Ashworth Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham Commun Dis Public Health 3 2000 132 134
75. P. Strebel, J. Nordin, and K. Edwards Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996 J Infect Dis 183 2001 1353 1359
76. W.K. Yih, S.M. Lett, and F.N. des Vignes The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998 J Infect Dis 182 2000 1409 1416
77. G. De Serres, R. Shadmani, and B. Duval Morbidity of pertussis in adolescents and adults J Infect Dis 182 2000 174 179
78. S. Baron, E. Njamkepo, and E. Grimprel Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination Pediatr Infect Dis J 17 1998 412 418
79. N.H. Birkebaek, M. Kristiansen, and T. Seefeldt Bordetella pertussis and chronic cough in adults Clin Infect Dis 29 1999 1239 1242
80. S. Postels-Multani, H.J. Schmitt, and C.H. Wirsing von Konig Symptoms and complications of pertussis in adults Infection 23 1995 139 142
81. J.G. Scott, D. Cohen, and B. DiCicco-Bloom Antibiotic use in acute respiratory infections and the ways patients pressure physicians for a prescription J Fam Pract 50 2001 853 858
82. B. Trollfors Effect of erythromycin and amoxycillin on Bordetella pertussis in the nasopharynx Infection 6 1978 228 230
83. C.M. Mink, J.D. Cherry, and P. Christenson A search for Bordetella pertussis infection in university students Clin Infect Dis 14 1992 464 471
84. P.W. Robertson, H. Goldberg, and B.H. Jarvie Bordetella pertussis infection: a cause of persistent cough in adults Med J Aust 146 1987 522 525
85. S. Rosenthal, P. Strebel, and P. Cassiday Pertussis infection among adults during the 1993 outbreak in Chicago J Infect Dis 171 1995 1650 1652
86. S. Schmitt-Grohe, J.D. Cherry, and U. Heininger Pertussis in German adults Clin Infect Dis 21 1995 860 866
87. L.D. Senzilet, S.A. Halperin, and J.S. Spika Pertussis is a frequent cause of prolonged cough illness in adults and adolescents Clin Infect Dis 32 2001 1691 1697
88. S.W. Wright, K.M. Edwards, and M.D. Decker Pertussis seroprevalence in emergency department staff Ann Emerg Med 24 1994 413 417
89. M. Campins-Marti, H.K. Cheng, and K. Forsyth Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration Vaccine 20 2001 641 646
90. M. Granstrom, M. Thoren, and M. Blennow Acellular pertussis vaccine in adults: adverse reactions and immune response Eur J Clin Microbiol 6 1987 18 21
91. W.A. Keitel, L.R. Muenz, and M.D. Decker A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization J Infect Dis 180 1999 397 403
92. J. Storsaeter, W.C. Blackwelder, and H.O. Hallander Pertussis antibodies, protection, and vaccine efficacy after household exposure Am J Dis Child 146 1992 167 172
93. J. Ward, S. Partridge, and S. Chang Acellular pertussis vaccine efficacy and epidemiology of pertussis in adolescents and adults: NIH multicenter adult pertussis trial (APERT) 2000 National Institutes of Health Bethesda (MD)
94. H.W. Hethcote Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations Math Biosci 158 1999 47 73
95. S.O. Bergquist, S. Bernander, and H. Dahnsjo Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects Pediatr Infect Dis J 6 1987 458 461
96. M.A. Sprauer, S.L. Cochi, and E.R. Zell Prevention of secondary transmission of pertussis in households with early use of erythromycin Am J Dis Child 146 1992 177 181
97. C.H. Wirsing von Konig, S. Postels-Multani, and H. Bogaerts Factors influencing the spread of pertussis in households Eur J Pediatr 157 1998 391 394
98. R.W. Steketee, S.G. Wassilak, and W.N. Adkins Jr. Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled J Infect Dis 157 1988 434 440
99. P. Diehr, R.W. Wood, and J. Bushyhead Prediction of pneumonia in outpatients with acute cough-a statistical approach J Chronic Dis 37 1984 215 225
100. C.L. Emerman, N. Dawson, and T. Speroff Comparison of physician judgment and decision aids for ordering chest radiographs for pneumonia in outpatients Ann Emerg Med 20 1991 1215 1219
101. J.P. Metlay, W.N. Kapoor, and M.J. Fine Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination JAMA 278 1997 1440 1445
102. P. Gennis, J. Gallagher, and C. Falvo Clinical criteria for the detection of pneumonia in adults: guidelines for ordering chest roentgenograms in the emergency department J Emerg Med 7 1989 263 268
103. P.S. Heckerling, T.G. Tape, and R.S. Wigton Clinical prediction rule for pulmonary infiltrates Ann Intern Med 113 1990 664 670
104. B.M. Singal, J.R. Hedges, and K.L. Radack Decision rules and clinical prediction of pneumonia: evaluation of low-yield criteria Ann Emerg Med 18 1989 13 20
105. J.L. Gerberding Sputum aeruginosa: time to rewrite the textbooks on virus-induced airway inflammation Am J Med 108 2000 91 92
106. L. Kaiser, D. Lew, and B. Hirschel Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions Lancet 347 1996 1507 1510
107. J.P. Metlay, R. Schulz, and Y.H. Li Influence of age on symptoms at presentation in patients with community-acquired pneumonia Arch Intern Med 157 1997 1453 1459
108. J.P. Metlay, and M.J. Fine Testing strategies in the initial management of patients with community-acquired pneumonia Ann Intern Med 138 2003 109 118
109. M.K. Albazzaz, C. Pal, and P. Berman Inflammatory markers of lower respiratory tract infection in elderly people Age Ageing 23 1994 299 302
110. J. Almirall, I. Bolibar, and P. Toran Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Chest 125 2004 1335 1342
111. S.A. Flanders, J. Stein, and G. Shochat Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough Am J Med 116 2004 529 535
112. V.E. Garcia, J.A. Martinez, and J. Mensa C-reactive protein levels in community-acquired pneumonia Eur Respir J 21 2003 702 705
113. R.M. Hopstaken, J.W. Muris, and J.A. Knottnerus Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection Br J Gen Pract 53 2003 358 364
114. A. Ortqvist, J. Hedlund, and B. Wretlind Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia Scand J Infect Dis 27 1995 457 462
115. H.I. Requejo, and A.M. Cocoza C-reactive protein in the diagnosis of community-acquired pneumonia Braz J Infect Dis 7 2003 241 244
116. R.P. Smith, and B.J. Lipworth C-reactive protein in simple community-acquired pneumonia Chest 107 1995 1028 1031
117. R.P. Smith, B.J. Lipworth, and I.A. Cree C-reactive protein. A clinical marker in community-acquired pneumonia Chest 108 1995 1288 1291
118. M. Assicot, D. Gendrel, and H. Carsin High serum procalcitonin concentrations in patients with sepsis and infection Lancet 341 1993 515 518
119. B. Muller, K.L. Becker, and H. Schachinger Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit Crit Care Med 28 2000 977 983
120. W. Karzai, M. Oberhoffer, and A. Meier-Hellmann Procalcitonin - a new indicator of the systemic response to severe infections Infection 25 1997 329 334
121. E. Nylen, B. Muller, and K.L. Becker The future diagnostic role of procalcitonin levels: the need for improved sensitivity Clin Infect Dis 36 2003 823 824
122. M. Christ-Crain, D. Jaccard-Stolz, and R. Bingisser Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial Lancet 363 2004 600 607
123. R. Gonzales, J.F. Steiner, and M.A. Sande Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians JAMA 278 1997 901 904
124. R.A. Meza, C. Bridges-Webb, and G.P. Sayer The management of acute bronchitis in general practice: results from the Australian Morbidity and Treatment Survey, 1990-1991 Aust Fam Physician 23 1994 1550 1553
125. T.J. Verheij, J. Hermans, and A.A. Kaptein Acute bronchitis: general practitioners' views regarding diagnosis and treatment Fam Pract 7 1990 175 180
126. T. Fahey, N. Stocks, and T. Thomas Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults BMJ 316 1998 906 910
127. L. Becker, R. Glazier, and W. McIsaac Antibiotics for acute bronchitis Cochrane Database Syst Rev 2000 CD000245
128. S. Bent, S. Saint, and E. Vittinghoff Antibiotics in acute bronchitis: a meta-analysis Am J Med 107 1999 62 67
129. A.T. Evans, S. Husain, and L. Durairaj Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial Lancet 359 2002 1648 1654
130. C.M. Kunin Resistance to antimicrobial drugs - a worldwide calamity Ann Intern Med 118 1993 557 561
131. J. Lederberg Infectious disease - a threat to global health and security JAMA 276 1996 417 419
132. S.B. Levy Confronting multidrug resistance. A role for each of us JAMA 269 1993 1840 1842
133. D.K. Chen, A. McGeer, and J.C. de Azavedo Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network N Engl J Med 341 1999 233 239
134. G.V. Doern, A.B. Brueggemann, and H. Huynh Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98 Emerg Infect Dis 5 1999 757 765
135. C.G. Whitney, M.M. Farley, and J. Hadler Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States N Engl J Med 343 2000 1917 1924
136. D.J. Diekema, A.B. Brueggemann, and G.V. Doern Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae Emerg Infect Dis 6 2000 552 556
137. J. Hofmann, M.S. Cetron, and M.M. Farley The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta N Engl J Med 333 1995 481 486
138. F. Moreno, C. Crisp, and J.H. Jorgensen The clinical and molecular epidemiology of bacteremias at a university hospital caused by pneumococci not susceptible to penicillin J Infect Dis 172 1995 427 432
139. J.M. Nava, F. Bella, and J. Garau Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study Clin Infect Dis 19 1994 884 890
140. J.P. Nuorti, J.C. Butler, and J.M. Crutcher An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents N Engl J Med 338 1998 1861 1868
141. R. Gonzales, D.C. Malone, and J.H. Maselli Excessive antibiotic use for acute respiratory infections in the United States Clin Infect Dis 33 2001 757 762
142. O. Cars, S. Molstad, and A. Melander Variation in antibiotic use in the European Union Lancet 357 2001 1851 1853
143. J.P. Metlay, J. Hofmann, and M.S. Cetron Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia Clin Infect Dis 30 2000 520 528
144. A.G. Mainous III, W.J. Hueston, and C. Eberlein Colour of respiratory discharge and antibiotic use Lancet 350 1997 1077
145. A.G. Mainous III, R.J. Zoorob, and M.J. Oler Patient knowledge of upper respiratory infections: implications for antibiotic expectations and unnecessary utilization J Fam Pract 45 1997 75 83
146. A.C. Nyquist, R. Gonzales, and J.F. Steiner Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis JAMA 279 1998 875 877
147. R. Gonzales, J.F. Steiner, and J. Maselli Impact of reducing antibiotic prescribing for acute bronchitis on patient satisfaction Eff Clin Pract 4 2001 105 111
148. A. Kleinman, L. Eisenberg, and B. Good Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research Ann Intern Med 88 1978 251 258
149. R. Gonzales, A. Wilson, and L.A. Crane What's in a name? Public knowledge, attitudes, and experiences with antibiotic use for acute bronchitis Am J Med 108 2000 83 85
150. R.M. Hamm, R.J. Hicks, and D.A. Bemben Antibiotics and respiratory infections: are patients more satisfied when expectations are met? J Fam Pract 43 1996 56 62
151. R. Mangione-Smith, E.A. McGlynn, and M.N. Elliott The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior Pediatrics 103 1999 711 718
152. J.M. Hutchinson, and R.N. Foley Method of physician remuneration and rates of antibiotic prescription CMAJ 160 1999 1013 1017
153. J.P. Metlay, J.A. Shea, and L.B. Crossette Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients J Gen Intern Med 17 2002 87 94
154. H. Bauchner, S.I. Pelton, and J.O. Klein Parents, physicians, and antibiotic use Pediatrics 103 1999 395 401
155. R. Gonzales, J.F. Steiner, and A. Lum Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults JAMA 281 1999 1512 1519
156. W.J. Hueston, R. Jenkins, and A.G. Mainous III Does drug treatment of patients with acute bronchitis reduce additional care seeking? Evidence from the Practice Partner Research Network Arch Fam Med 9 2000 997 1001
157. T. Jefferson, V. Demicheli, and J. Deeks Neuraminidase inhibitors for preventing and treating influenza in healthy adults Cochrane Database Syst Rev 2000 CD001265
158. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group Lancet 352 1998 1877 1881
159. L. Kaiser, M.S. Briones, and F.G. Hayden Performance of virus isolation and Directigen Flu A to detect influenza A virus in experimental human infection J Clin Virol 14 1999 191 197
160. D.E. Noyola, B. Clark, and F.T. O'Donnell Comparison of a new neuraminidase detection assay with an enzyme immunoassay, immunofluorescence, and culture for rapid detection of influenza A and B viruses in nasal wash specimens J Clin Microbiol 38 2000 1161 1165
161. T.O. Jefferson, and D. Tyrrell Antivirals for the common cold Cochrane Database Syst Rev 2001 CD002743
162. M.D. McColl, R.B. Corser, and J. Bremner Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin Bone Marrow Transplant 21 1998 423 425
163. W.J. Hueston A comparison of albuterol and erythromycin for the treatment of acute bronchitis J Fam Pract 33 1991 476 480
164. W.J. Hueston Albuterol delivered by metered-dose inhaler to treat acute bronchitis J Fam Pract 39 1994 437 440
165. H. Melbye, U. Aasebo, and B. Straume Symptomatic effect of inhaled fenoterol in acute bronchitis: a placebo-controlled double-blind study Fam Pract 8 1991 216 222
166. B. Littenberg, M. Wheeler, and D.S. Smith A randomized controlled trial of oral albuterol in acute cough J Fam Pract 42 1996 49 53
167. J.J. Smucny, C.A. Flynn, and L.A. Becker Are beta2-agonists effective treatment for acute bronchitis or acute cough in patients without underlying pulmonary disease? A systematic review J Fam Pract 50 2001 945 951
168. R.M. Douglas, E.B. Chalker, and B. Treacy Vitamin C for preventing and treating the common cold Cochrane Database Syst Rev 2000 CD000980
169. I. Marshall Zinc for the common cold Cochrane Database Syst Rev 2000 CD001364
170. D. Melchart, K. Linde, and P. Fischer Echinacea for preventing and treating the common cold Cochrane Database Syst Rev 2000 CD000530
171. C.M. Gilroy, J.F. Steiner, and T. Byers Echinacea and truth in labeling Arch Intern Med 163 2003 699 704
172. H. Matthys, R. Eisebitt, and B. Seith Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial Phytomedicine 10 Suppl 4 2003 7 17
173. J.A. Linder, and D.E. Singer Health-related quality of life of adults with upper respiratory tract infections J Gen Intern Med 18 2003 802 807